| Atul Bhatnagar, DO | |
|
55 Whitcher St Ne, Suite 160, Marietta, GA 30060-1155 | |
| (770) 422-1372 | |
| (770) 423-9651 |
| Full Name | Atul Bhatnagar |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 31 Years |
| Location | 55 Whitcher St Ne, Marietta, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1871595744 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 054177 (Georgia) | Secondary |
| 207RC0200X | Internal Medicine - Critical Care Medicine | 054177 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Wellstar Kennestone Hospital | Marietta, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wellstar Medical Group, Llc | 6709065402 | 1839 |
News Archive
GNI Ltd and EpiCept Corporation have announced that they have reached agreement to develop a new therapeutic drug, EP1013, in Asia, Australia, and New Zealand, for late-stage viral infection-induced hepatitis. EpiCept will retain the rights in the rest of the world. GNI's wholly owned subsidiary, Shanghai Genomics, will start preparation for pre-IND and clinical development in China immediately.
A team of researchers has found that doses of bilirubin help provide suppression of the immune response following islet transplantation in mouse models.
Summaries of studies recently published in the Journal of Infectious Diseases.
As more and more youth use electronic cigarettes, combined with research showing the health consequences of vaping - including nicotine addiction - researchers at the University of North Carolina-Chapel Hill found that non-menthol flavors attract youth and adults to use e-cigarettes and that the use of flavored e-cigarettes contributes to multiple pathways linked to higher e-cigarette use among youth.
› Verified 6 days ago
| Entity Name | Piedmont Healthcare Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376624940 PECOS PAC ID: 3274529524 Enrollment ID: O20040423000767 |
News Archive
GNI Ltd and EpiCept Corporation have announced that they have reached agreement to develop a new therapeutic drug, EP1013, in Asia, Australia, and New Zealand, for late-stage viral infection-induced hepatitis. EpiCept will retain the rights in the rest of the world. GNI's wholly owned subsidiary, Shanghai Genomics, will start preparation for pre-IND and clinical development in China immediately.
A team of researchers has found that doses of bilirubin help provide suppression of the immune response following islet transplantation in mouse models.
Summaries of studies recently published in the Journal of Infectious Diseases.
As more and more youth use electronic cigarettes, combined with research showing the health consequences of vaping - including nicotine addiction - researchers at the University of North Carolina-Chapel Hill found that non-menthol flavors attract youth and adults to use e-cigarettes and that the use of flavored e-cigarettes contributes to multiple pathways linked to higher e-cigarette use among youth.
› Verified 6 days ago
| Entity Name | Wellstar Medical Group, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558664003 PECOS PAC ID: 6709065402 Enrollment ID: O20110127000374 |
News Archive
GNI Ltd and EpiCept Corporation have announced that they have reached agreement to develop a new therapeutic drug, EP1013, in Asia, Australia, and New Zealand, for late-stage viral infection-induced hepatitis. EpiCept will retain the rights in the rest of the world. GNI's wholly owned subsidiary, Shanghai Genomics, will start preparation for pre-IND and clinical development in China immediately.
A team of researchers has found that doses of bilirubin help provide suppression of the immune response following islet transplantation in mouse models.
Summaries of studies recently published in the Journal of Infectious Diseases.
As more and more youth use electronic cigarettes, combined with research showing the health consequences of vaping - including nicotine addiction - researchers at the University of North Carolina-Chapel Hill found that non-menthol flavors attract youth and adults to use e-cigarettes and that the use of flavored e-cigarettes contributes to multiple pathways linked to higher e-cigarette use among youth.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Atul Bhatnagar, DO 55 Whitcher St Ne, Suite 160, Marietta, GA 30060-1155 Ph: (770) 422-1372 | Atul Bhatnagar, DO 55 Whitcher St Ne, Suite 160, Marietta, GA 30060-1155 Ph: (770) 422-1372 |
News Archive
GNI Ltd and EpiCept Corporation have announced that they have reached agreement to develop a new therapeutic drug, EP1013, in Asia, Australia, and New Zealand, for late-stage viral infection-induced hepatitis. EpiCept will retain the rights in the rest of the world. GNI's wholly owned subsidiary, Shanghai Genomics, will start preparation for pre-IND and clinical development in China immediately.
A team of researchers has found that doses of bilirubin help provide suppression of the immune response following islet transplantation in mouse models.
Summaries of studies recently published in the Journal of Infectious Diseases.
As more and more youth use electronic cigarettes, combined with research showing the health consequences of vaping - including nicotine addiction - researchers at the University of North Carolina-Chapel Hill found that non-menthol flavors attract youth and adults to use e-cigarettes and that the use of flavored e-cigarettes contributes to multiple pathways linked to higher e-cigarette use among youth.
› Verified 6 days ago
Anu Kurl, MD Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 400 Tower Rd Ne Ste 160, Marietta, GA 30060 Phone: 770-420-1690 Fax: 770-420-1661 | |
Dr. Sharon M Odell, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 54 Tower Rd Ne, Marietta, GA 30060 Phone: 770-427-4682 Fax: 770-499-8562 | |
Dr. Helga Annalina Bahr, M.D. Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 580 Atlanta Country Club Drive, Marietta, GA 30068 Phone: 770-988-8554 | |
Dr. Kaynessa Celena Providence, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 54 Tower Rd Ne, Marietta, GA 30060 Phone: 770-427-4682 Fax: 770-499-8562 | |
Dr. Ryan V Cantwell, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 320 Kennestone Hospital Blvd, Suite 201, Marietta, GA 30060 Phone: 770-427-2457 Fax: 770-427-2706 | |
Dr. Joanne Zhiwen Zhu, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 677 Church St Ne # 111, Marietta, GA 30060 Phone: 770-793-7750 | |
Asif A Saberi, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 55 Whitcher St Ne, Suite 160, Marietta, GA 30060 Phone: 770-422-1372 Fax: 770-423-9651 |